Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | MET | P08581 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12710425 | 0.84 | LMNA (0.47) | LMNAALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL13417758 | 0.83 | LMNA (0.58) | LMNAALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL13502010 | 0.79 | MAPT (0.47) | LMNAALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL31327423 | 0.75 | THRB (0.44) | LMNAALDH1A1MEN1KMT2ACA1 | |
| SCHEMBL16979274 | 0.75 | THRB (0.44) | LMNAALDH1A1MEN1KMT2ACA1 | |
| SCHEMBL4645538 | 0.73 | TSHR (0.57) | LMNAALDH1A1MAPK1THRB | |
| SCHEMBL13501905 | 0.72 | S100A4 (0.51) | ALDH1A1MEN1KMT2ACA1CA2 | |
| SCHEMBL13453561 | 0.72 | POLB (0.59) | LMNAALDH1A1MEN1KMT2ACA1 | |
| SCHEMBL13567306 | 0.72 | THRB (0.49) | ALDH1A1KMT2ACA1CA2CA9 | |
| SCHEMBL19160203 | 0.72 | THRB (0.42) | LMNAALDH1A1MEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1928931-B1 | CROSSLINKED POLYMERS WITH AMINE BINDING GROUPS | 3M INNOVATIVE PROPERTIES CO (US) | 2011-04-06 | — | — | EP | disclosed |
| US-7671155-B2 | Crosslinked polymers with amine binding groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-03-02 | — | — | US | disclosed |
| US-7667046-B2 | N-sulfonyldicarboximide containing tethering compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-02-23 | — | — | US | disclosed |
| US-7667046-B2 | N-sulfonyldicarboximide containing tethering compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-02-23 | — | — | US | disclosed |
| US-20090214794-A1 | CROSSLINKED POLYMERS WITH AMINE BINDING GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2009-08-27 | — | — | US | disclosed |
| US-7544756-B2 | Crosslinked polymers with amine binding groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-06-09 | — | — | US | disclosed |
| US-7423155-B2 | N-sulfonyldicarboximide containing tethering compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-09-09 | — | — | US | disclosed |
| US-20080145907-A1 | N-SULFONYLDICARBOXIMIDE CONTAINING TETHERING COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY | 2008-06-19 | — | — | US | disclosed |
| WO-2007040968-A2 | CROSSLINKED POLYMERS WITH AMINE BINDING GROUPS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-04-12 | — | — | WO | disclosed |
| US-20070078244-A1 | Crosslinked polymers with amine binding groups | 3M INNOVATIVE PROPERTIES COMPANY | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080145907-A1 | N-SULFONYLDICARBOXIMIDE CONTAINING TETHERING COMPOUNDS | NAPA, MSN, NSFL1C | LMNA 577/4885ALDH1A1 1066/4885MEN1 614/4885 |
| US-20070078244-A1 | Crosslinked polymers with amine binding groups | PAM, MSN, PARG | LMNA 784/4885ALDH1A1 2104/4885MEN1 2419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.